Mirae Asset Global Investments Co., Ltd. Stoke Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$4.12 - $14.17 $373,531 - $1.28 Million	90,663 New	90,663 $1.22 Million
Q3 2023 Oct 26, 2023	BUY	$3.78 - $11.99 $47,166 - $149,611	12,478 Added 9.34%	146,076 $575,000
Q2 2023 Aug 10, 2023	BUY	$7.93 - $13.82 $327,049 - $569,964	41,242 Added 44.66%	133,598 $1.42 Million
Q1 2023 May 04, 2023	BUY	$7.65 - $10.38 $5,668 - $7,691	741 Added 0.81%	92,356 $769,000
Q4 2022 Feb 09, 2023	SELL	$7.07 - $15.69 $19,357 - $42,959	-2,738 Reduced 2.9%	91,615 $845,000
Q3 2022 Nov 10, 2022	BUY	$12.56 - $22.53 $170,250 - $305,394	13,555 Added 16.78%	94,353 $1.21 Million
Q2 2022 Jul 26, 2022	BUY	$10.36 - $23.93 $837,067 - $1.93 Million	80,798 New	80,798 $1.07 Million

123

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $474M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.